Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

In the month of October, many organizations use the color pink to raise awareness for breast cancer. Women are encouraged to do regular home exams and to attend their annual mammograms. For men, ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

After much deliberation, a government advisory committee announced on Friday afternoon that it will not be recommending population-wide prostate cancer screening in the UK. The UK National Screening ...

Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...

Former President Joe Biden was diagnosed last week with an aggressive form of prostate cancer that has spread to his bones. The news has raised lots of questions about the typically slow-growing ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.